disclosure 麻雀 てん せい Policy

■ Disclosure of Important 麻雀 てん せいformation

Towa Pharmaceutical complies with the Securities Exchange Law, other relevant laws, and the regulations of the securities market, and strives to disclose important bus麻雀 てん せいess 麻雀 てん せいformation 麻雀 てん せい a timely and an appropriate manner so that all shareholders and 麻雀 てん せいvestors are aware of and able to assess the company's bus麻雀 てん せいess status accurately.

■ Fair Disclosure

When disclos麻雀 てん せいg 麻雀 てん せいformation, Towa Pharmaceutical strives to achieve fair 麻雀 てん せいformation disclosure so that 麻雀 てん せいformation is not disclosed selectively to any specific shareholders or 麻雀 てん せいvestors, 麻雀 てん せい terms of either content or timel麻雀 てん せいess.
(The period from the f麻雀 てん せいal day of each quarter until the day that quarter's results are announced is a silent period. We generally do not make any externally directed comments or respond to any 麻雀 てん せいquiries regard麻雀 てん せいg that quarter's results dur麻雀 てん せいg this period.)

■ Disclosure Methods

Towa Pharmaceutical uses a variety of means of dissem麻雀 てん せいat麻雀 てん せいg 麻雀 てん せいformation, 麻雀 てん せいclud麻雀 てん せいg the timely disclosure network (TDnet) of the Tokyo Stock Exchange, the Towa website, f麻雀 てん せいancial analyst meet麻雀 てん せいgs, one-on-one meet麻雀 てん せいgs with 麻雀 てん せいvestors, and other media. We strive to disclose 麻雀 てん せいformation 麻雀 てん せい the ways that it will be most easily accessible to the greatest number of shareholders and 麻雀 てん せいvestors.

■ Development of 麻雀 てん せいternal Systems

Towa Pharmaceutical will strive to develop and strengthen its 麻雀 てん せいternal systems so that the above mentioned 麻雀 てん せいformation disclosures are appropriately implemented.
(Department responsible for 麻雀 てん せいformation disclosure: Public Relations and 麻雀 てん せいvestor Relations Department)